[Behavior of lactate and pyruvate in diabetics treated with a combination of fenformin and sulfonylurea in varying doses. I].
D000328:Adult; D000368:Aged; D002747:Chlorpropamide / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000378:metabolism; D016883:Diabetic Ketoacidosis / Q000209:etiology; D004338:Drug Combinations; D005260:Female; D005905:Glyburide / Q000627:therapeutic use; D006801:Humans; D007773:Lactates / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010629:Phenformin / Q000008:administration & dosage* / Q000627:therapeutic use; D011773:Pyruvates / Q000378:metabolism*; D013453:Sulfonylurea Compounds / Q000008:administration & dosage* / Q000627:therapeutic use
D004338:Drug Combinations; D007773:Lactates; D011773:Pyruvates; D013453:Sulfonylurea Compounds; D010629:Phenformin; D005905:Glyburide; D002747:Chlorpropamide
Comportamento del lattato e piruvato in diabetici trattati con associazione fenformina-sulfoniluree a dosi variabili. Nota i.